Igene Biotechnology, Inc.
IGNE
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | 09/30/2009 | |
|---|---|---|---|---|---|
| Revenue | 4.80K | 1.12M | 2.72M | 3.96M | 5.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.80K | 1.12M | 2.72M | 3.96M | 5.34M |
| Cost of Revenue | -36.00K | 425.50K | 2.00M | 2.94M | 4.54M |
| Gross Profit | 40.80K | 695.10K | 718.90K | 1.02M | 792.00K |
| SG&A Expenses | 943.60K | 1.06M | 1.10M | 1.25M | 1.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.35M | -2.39M | -2.16M | -2.09M | -1.53M |
| Total Operating Expenses | 601.50K | 1.05M | 2.79M | 3.97M | 6.34M |
| Operating Income | -596.70K | 70.30K | -73.00K | -11.20K | -1.00M |
| Income Before Tax | -2.37M | -1.63M | -1.42M | -176.70K | -1.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.37 | -1.63 | -1.42 | -0.18 | -1.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.37M | -1.63M | -1.42M | -176.70K | -1.16M |
| EBIT | -596.70K | 70.30K | -73.00K | -11.20K | -1.00M |
| EBITDA | -427.10K | 243.40K | 104.10K | 170.20K | -692.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 6.25B | 6.24B | 6.19B | 6.15B | 5.01B |
| Average Diluted Shares Outstanding | 6.25B | 6.24B | 6.19B | 6.15B | 5.01B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |